Skip to main content
. 2022 Nov 17;13:1044030. doi: 10.3389/fendo.2022.1044030

Figure 4.

Figure 4

Differences in bacterial abundance between patients with and without adverse events. (A) the group similarity of samples at the genus level; (B) the different genera in patients without and with gastrointestinal adverse events after treatment; (C) the LEfSe analysis. AE, adverse events; T, treatment.